Mg. Eason et al., THE PALMITOYLATED CYSTEINE OF THE CYTOPLASMIC TAIL OF ALPHA(2A)-ADRENERGIC RECEPTORS CONFERS SUBTYPE-SPECIFIC AGONIST-PROMOTED DOWN-REGULATION, Proceedings of the National Academy of Sciences of the United Statesof America, 91(23), 1994, pp. 11178-11182
Most guanine nucleotide binding protein (G protein)-coupled receptors
have a conserved cysteine in the C-terminal cytoplasmic tail near the
seventh transmembrane spanning region. This cysteine is known to be pa
lmitoylated in rhodopsin, the beta(2)-adrenergic receptor (beta(2)AR)
and the alpha(2A)-adrenergic receptor (alpha(2A)AR). For the beta(2)AR
, this cysteine has been shown to be important for stimulatory G prote
in (G(s)) coupling and agonist-promoted desensitization. For the alpha
(2A)AR (human alpha(2)C10) palmitoylation occurs at Cys-442, but it is
not known what function such fatty acid acylation subserves. The clos
ely related alpha(2C)AR subtype denoted alpha(2)C4 lacks a cysteine in
this region and has different G-protein-coupling characteristics and
agonist regulatory properties as compared to alpha(2)C10. To assess th
e role of the palmitoylcysteine in alpha(2)AR function, we constructed
a mutated alpha(2)C10 having a phenylalanine (the analogous amino aci
d in the alpha(2)C4 in this position) substituted for Cys-442, denoted
alpha(2)C10(Phe-442), and expressed this along with wild-type alpha(2
)C10 and alpha(2)C4 in CHO cells. Functional coupling to inhibitory G
protein (G(i)) and to G(s) was identical between wild-type alpha(2)C10
and alpha(2)C10(Phe-442). Agonist-promoted desensitization of both th
e G(i) and G(s)-mediated pathways was also found to be unaffected by t
his mutation. Cellular trafficking induced by agonist exposure was eva
luated by delineation of intracellular (sequestered) versus cell surfa
ce receptors and by determination of net receptor loss. Mutation of Cy
s-442 did not alter the extent or rate of agonist-promoted sequestrati
on induced by agonists or the recovery from sequestration. However, th
e downregulation of receptor number after prolonged agonist exposure w
as completely abolished by this mutation and converted alpha(2)C10 to
an alpha(2)C4 phenotype in regard to this adaptive response. Another m
utated alpha(2)C10, in which Cys-442 was replaced by alanine, also fai
led to downregulate. Thus, the function of this cytoplasmic palmitoylc
ysteine is distinctly different between the alpha(2)AR and other G-pro
tein-coupled receptors such as the beta(2)AR and rhodopsin, and this s
uggests that this molecular attribute may subserve diverse roles among
members of this family of receptors. For the alpha(2)ARs, this may re
present an evolved feature that provides for differing needs for regul
ation of the alpha(2)C10 and alpha(2)C4 subtypes by agonist.